Optimer Pharmaceuticals files for $100 mln shelf
[2008-3-31]
Optimer Pharmaceuticals Inc (OPTR.O: Quote, Profile, Research) on Thursday filed to periodically sell up to $100 million in common and preferred stock, debt securities, warrants and units.
The company said in a filing with the U.S. Securities and Exchange Commission that it would use proceeds from the offering for research and development and general corporate purposes.
Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale. (Reporting by Karey Wutkowski, editing by Richard Chang)
The company said in a filing with the U.S. Securities and Exchange Commission that it would use proceeds from the offering for research and development and general corporate purposes.
Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale. (Reporting by Karey Wutkowski, editing by Richard Chang)
Related News »
In Focus »
footwear exports
Last month, European footwear manufacturers proposed extending anti-dumping measures against ..
B2B Keywords:
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product




